ÂÜÀòÂÒÂ×

Diana Monica Batin has extensive work experience in the medical field. Diana Monica is currently employed as a Medical Director at ARENSIA Exploratory Medicine GmbH since September 2022. From 2016 to 2022, they worked as a CRA at PPD, where they performed clinical monitoring and site management, adhering to various guidelines and regulations. Prior to that, they held positions at S.C. Kynetyx HT S.R.L. from 2010 to 2016, where they served as a Clinical Investigator and Head of Clinical Operations, and at S.C. Kynetyx HT S.R.L. from 2007 to 2010, where they worked as a Clinical Investigator and Head of Clinical Unit. Diana also worked as a Clinical Unit Manager at Terapia Ranbaxy from 2006 to 2007. Diana Monica gained experience as a Clinical Investigator and Clinical subinvestigator at Terapia S.A. from 2003 to 2006, and as a Competence in Community Medicine at Cluj Napoca County Hospital in 2003. Diana Monica began their medical career as a Family Medicine resident physician at Cluj-Napoca County Hospital from 2000 to 2003 and as a Probationer/Intern Physician at Cluj Napoca Adult Clinical Hospital from 1999 to 2000.

Diana Monica Batin has a diverse education history in the medical field. In 1998, they obtained a medical doctor degree from the University of Medicine and Pharmacy Cluj Napoca in Romania. Following this, in 2000, they completed their degree in Family Medicine from the Cluj Napoca University of Medicine and Pharmacy. In 2003, they gained competence in Community Medicine at the same university and also studied Bioequivalence at the Romanian Society of Pharmaceutical Sciences. In 2004, they attended the National Agency for Medicine and Medical Devices where they focused on Good Clinical Practice (GCP). The following year, in 2005, they completed a management course at AIMS and also undertook GCP training at the Clinical Research Center Romania CRCRo. In 2006, they received a Certificate of Concilor from the "Prof. dr. Matei Bals" Institute of Infections Disease and Romania Angel Appeal Foundation. Furthermore, in 2007, they participated in a pharmacovigilance course at Terapia Ranbaxy Company and obtained a GCP certificate from VERUM EDU. In 2008, they pursued clinical trial studies at the Drug Information Association. Diana's education continued with GCP training at SCEPTER TM in 2011, Astra Nova training in 2013, and NIDA Clinical Trials Network in 2014. Finally, in 2016, they completed a GCP course at Whitehall Training. Overall, Diana Monica Batin has continually expanded their knowledge and expertise in various aspects of clinical trials and pharmaceutical research throughout their education journey.